TCL Archive Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds June 29, 2007
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund October 25, 1985
TCL Archive After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant June 11, 2014
